A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
Clinical trial NCT05394519 · COMPLETED
Trial details
- NCT number
- NCT05394519
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2025-01-28
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.